Proceedings of the 1st International Conference for Cancer Metabolism and Therapy, October 14–17, 2016, Dalian, China
The goals of the conference were to invite national and international experts to present and discuss precision medicine focused on cancer metabolism and therapy. Cancer metabolism is intimately linked to drug resistance, which is currently one of the most important challenges in cancer therapy. Recent advancement of novel high-throughput technologies, such as genomics, transcriptomics, proteomics, metabolomics, phenomics, and mega-data bioinformatics (core technology of precision medicine), has been significantly enhanced our understanding of metabolic properties related to malignancy, paving the way for development of biomarker used for early diagnosis and prognosis of cancer, and effective selection of molecular targets for therapeutic interventions. As the burden of cancer is rampantly increasing and posing challenges in early diagnosis and treatment, this is identifying the genuine need in the area and its implementation for patients. The conference covered a wide range of topics in cancer such as etiology, epidemiology, metabolic reprogramming, environment altered i.e. surgical therapy, chemotherapy, and radiotherapy, and cancer stem cell therapy. Currently, cancer therapy and research are in a new era of rapid and significant developments not only in the West but also in Asia as well. Due to newly developed technology, we can now readily use many high-tech diagnostic tools, new anticancer drugs, molecular targeting chemotherapy, less invasive and/or less expensive and effective therapy that were unavailable in the near past. Therefore, it is crucial for scientists from all over the world to get together and to share your new ideas and thoughts with each other, especially for young scientists from all over the world who can communicate openly with the global leaders in the field, investigators, medical and surgical oncologists through your presentations and vigorous discussion. This conference has achieved its goals and will help bring about substantial advances in both cancer research and improvement in therapy for all cancer patients.
The next meeting is planned to be held October 13–October 16, 2017 in Wenzhou, Zhejiang, China. The meeting venue will be in Wenzhou Dynasty Grand Hotel, Zhejiang, China.